British drugmaker AstraZeneca Plc's first-quarter product sales beat analysts' expectations on Friday, benefiting from higher demand for its cancer medicines.
from Reuters: Company News https://reut.rs/2UFz4Wz
via IFTTT
from Reuters: Company News https://reut.rs/2UFz4Wz
via IFTTT
إرسال تعليق